FDA Clears Fate Therapeutics’ Dual-Target CAR-T FT839 for Autoimmune Diseases
Following positive FT819 data in systemic sclerosis, the company now targets multiple autoimmune indications.
NOTRELOAD AI
Oppenheimer Initiates Outperform Coverage on Connect Biopharma with $8 Target, Implies 3.6x Upside
Rademikibart’s rapid action in acute asthma & COPD positions it for major upside ahead of Phase 2 readouts.
TeraWulf Targets $3.5 Billion Debt Raise to Build Massive AI Data Center for Anthropic
TeraWulf is targeting $3.5B in leveraged loans to fund its Justified Data AI campus in Kentucky, fully leased to Anthropic under a $19 billion, 20-year agreement.
Qiagen Draws Early Takeover Interest from EQT, Advent, and KKR
No formal bids yet as the ~$9B molecular diagnostics leader faces sector consolidation.
MARA Holdings Acquires Massive 1.2 GW Powered Site in Texas for AI and Bitcoin Mining
The acquisition more than doubles MARA’s total power capacity to ~4.8 GW for AI computing and Bitcoin mining.
Paramount-Warner Bros. Merger Hits New Delays Amid Mounting Legal Challenges
Oregon AG investigation and multiple state lawsuits push the deadline to July 22, with a ticking fee looming.